Faculty Collaboration Database

Infantile hemangiomas: an update. Am J Clin Dermatol 2013 Apr;14(2):111-23

Date

01/23/2013

Pubmed ID

23338947

DOI

10.1007/s40257-013-0008-x

Scopus ID

2-s2.0-84879539406 (requires institutional sign-in at Scopus site)   36 Citations

Abstract

Infantile hemangioma (IH) is a common vascular tumor of infancy. Although benign, infants with IH can experience complications including ulceration, visual and airway impairment, and residual scarring and disfigurement. It is often challenging for clinicians to predict which tumors are in need of systemic treatment. However, data from various demographic and other studies have revealed further insights into this tumor. This article reviews the identification, evaluation, and management of high-risk IHs, including the indications for treatment and the use of systemic treatments such as corticosteroids, β-blockers, and vincristine.

Author List

Kwon EK, Seefeldt M, Drolet BA

MESH terms used to index this publication - Major topics in bold

Adrenal Cortex Hormones
Biopsy, Needle
Combined Modality Therapy
Dermatologic Surgical Procedures
Drug Therapy, Combination
Female
Follow-Up Studies
Hemangioma
Humans
Immunohistochemistry
Infant
Interferon-alpha
Low-Level Light Therapy
Male
Propranolol
Risk Assessment
Severity of Illness Index
Skin Neoplasms
Treatment Outcome
Vincristine